by Carl Rogel Inocentes
In the Philippines, cancer claims the lives of 56,000 Filipinos a year, making it one of the country’s top causes of death. Top cancer killers in the Philippines include breast, lung, colorectal, liver and cervical cancers.
“The increasing number of new cancer cases worldwide is alarming and it becomes more pressing for us to pursue strategic interventions,” said Dr. Christine Gruenberg of the Cardinal Santos Medical Center (CSMC).
Treatment methods cannot begin if there is no pathologic confirmation of the disease. This is why the availability of advanced healthcare technology matters in improving diagnosis, said GE Healthcare Philippines Country Manager Ivan Arota.
“Just like all other health challenges, addressing the burden of cancer requires a multi-sectoral approach. Our work as a healthcare solutions provider does not stop with the development of innovative medical equipment,” Arota said.
“We help build on the diagnostic capacity of healthcare workers pursuant to the recommendations of the WHO.”
CSMC’s latest effort to meet the Philippines’ needs on cancer care is the installation of the Discovery PET/CT 710. The Discovery PET/CT 710 features high sensitivity, advanced protocol flexibility, and high-definition image reconstruction to help doctors recommend the best possible tailor regimen for patients, while minimizing radiation.
A PET-CT scan is an invaluable diagnostic tool in cancer care that simultaneously performs two individual tests to detect cancer and determine its stage. The highly sensitive PET scan detects the metabolic signal of actively growing cancer cells – a key element in the diagnostic process; while the CT scan creates a detailed image of abnormal cancerous tissues inside the body, including their location and size.
The PET scanner picks up the signal produced by the marker, creating images of the FDG distribution in the body. Combined, a PET-CT scan provides doctors with comprehensive information on the disease and allows them to plan treatment effectively.
“When healthcare providers recommend treatment options to cancer patients, they rely heavily on data generated by equipment and other tools. We can’t compromise quality and efficient monitoring because lives are at stake,” said CSMC Medical Director Dr. Zenaida Javier-Uy.
“The addition of a PET/CT in CSMC’s range of equipment and services will help us in our commitment to provide improved cancer care and better clinical outcomes for our patients.”